MDPP can help patients, but earnings are unlikely the reason to offer it
Two years in as a billable service, the Medicare Diabetes Prevention Program (MDPP) has not achieved great penetration and does not promise large financial benefits for participating suppliers. But the benefit of care for patients is reported to be substantial, and under some payment models you may find the program worth offering.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.
Quick, Current, Complete - www.findacode.com